Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nowakowska

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
British Journal of Cancer|February 27, 2015
Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agentsM Crespo, G van Dalum, R Ferraldeschi, et al.
Nature Communications|September 7, 2021
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapseS Taavitsainen, N Engedal, S Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate CancerC T A Parker, H-C Huang, E Grist, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
British Journal of Cancer|February 27, 2015
Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agentsM Crespo, G van Dalum, R Ferraldeschi, et al.
Nature Communications|September 7, 2021
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapseS Taavitsainen, N Engedal, S Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate CancerC T A Parker, H-C Huang, E Grist, et al.
Pageof 3